News
Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...
For the primary endpoint, 62.5% (40/64) of patients treated demonstrated a Complete Response ("CR") (negative cystoscopy and negative urine cytology) at any point ... opportunity for an advancement in ...
The vaccine is being used on dogs with three types of cancer — osteosarcoma, hemangiosarcoma, and urothelial carcinoma, a form of bladder cancer. Cancer is the top cause of death for dogs.
Hosted on MSN16d
North Carolina dog a part of cancer vaccine trialMamula and his team are testing the treatment in three types of canine cancer: bladder cancer, osteosarcoma (bone cancer), and hemangiosarcoma, which affects the spleen. After several years of ...
Hosted on MSN16d
‘Part of something that could be huge’: Nash County dog part of clinical trial testing experimental canine cancer vaccineMamula and his team are testing the treatment in three types of canine cancer: bladder cancer, osteosarcoma (bone cancer), and hemangiosarcoma, which affects the spleen. After several years of ...
2don MSN
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...
2d
News-Medical.Net on MSNNew insights into decades-old bladder cancer treatment offers clues for immunotherapyMore than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...
8d
MedPage Today on MSNRecent Developments in Bladder CancerFrom a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...
Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder ...
Imfinzi is approved for muscle-invasive bladder cancer and is under investigation in various stages and combinations for bladder cancer treatment. Imfinzi plus BCG induction and maintenance therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results